STOXPO
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
  • Latest News
  • Technology
    • Software
    • Semiconductors
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions
No Result
View All Result
STOXPO
No Result
View All Result
Home Industrials Aerospace & Defense

KULR Launches AI & Robotics Unit Through Strategic Partnership With German Bionic

byLuca Blaumann
April 15, 2025
in Aerospace & Defense, Artificial Intelligence, Mid-Cap
Reading Time: 2 mins read
Share on TwitterShare on LinkedIn

New alliance aims to deliver cutting-edge exoskeleton technology across North America and boost U.S. manufacturing

KULR Technology (KULR) has entered into a strategic partnership with German Bionic, a global leader in robotic exoskeletons, marking a bold move into the rapidly growing robotics and AI space. The collaboration includes the formation of a new business unit, KULR AI & Robotics, dedicated to accelerating innovation and commercialization of next-gen wearable robotics.

German Bionic’s flagship product, the sixth-generation Apogee ULTRA, is already being used by major logistics firms, retailers, hospitals, and airports worldwide. Clients include Dachser Intelligent Logistics, GXO, Nuremberg Airport, and Charité Hospital Berlin. The global wearable robotic exoskeleton market is projected to hit $41.5 billion by 2033, according to Spherical Insights, offering significant growth potential for both companies.

KULR’s newly launched website, KULR.ai, underscores the company’s expanded focus. The new business unit will be led by Josh Steinmann, VP of AI and Robotics, and will play a central role in bringing advanced exoskeleton solutions to North American industries including manufacturing, healthcare, and logistics.

“This partnership exemplifies our strategy to use our energy management expertise to become a key enabler in the AI and robotics ecosystem,” said KULR CEO Michael Mo. “We’re focused on helping shape the future of human-machine collaboration.”

Under the deal, KULR will gain exclusive marketing and distribution rights for German Bionic’s products in North America. The companies will also collaborate on enhancing the Apogee ULTRA’s capabilities through improved performance, deeper AI integration, and increased adaptability for users.

Armin G. Schmidt, CEO of German Bionic, emphasized the importance of energy efficiency in wearable robotics. “Our exoskeletons are designed to elevate frontline workers and unlock their full potential. Partnering with KULR allows us to scale this vision.”

KULR also plans to localize future exoskeleton manufacturing in the U.S., aligning with national goals to strengthen domestic industry and supply chain resilience. With this partnership, KULR positions itself as a key player in the next wave of AI-powered, human-centered robotics.

Read original press release here

You might like this article:NATO Taps Palantir’s AI-Powered Maven System in Landmark Defense Deal

Tags: German BionicGrowthKULRMoversNewsStock Market
Previous Post

NATO Taps Palantir’s AI-Powered Maven System in Landmark Defense Deal

Next Post

Elliott Management Takes $1.5 Billion Stake in Hewlett Packard Enterprise

Related Posts

Investor Confidence Builds Around CoreWeave and Nebius Amid AI Infrastructure Boom

byLuca Blaumann
March 12, 2026
0

Strategic partnerships, expanding capacity, and Nvidia backing highlight growing momentum in the neocloud sector Investor confidence is increasing in AI...

Acurx Pharmaceuticals Shares Rise on New Clinical Trial Plans

byLuca Blaumann
March 11, 2026
0

Company advances C. difficile treatment program toward Phase 3 international studies Acurx Pharmaceuticals (ACXP) saw its shares move higher after...

trading-chart

ATPC Expands Global Energy Ambitions Through Strategic Partnership with Citadel Investment

byLiliana Vida
March 10, 2026
0

Collaboration targets international oil, gas, and petrochemical trading opportunities AGAPE ATP Corporation (ATPC), through its subsidiary ATPC Green Energy Sdn....

Next Post
trading-chart

Elliott Management Takes $1.5 Billion Stake in Hewlett Packard Enterprise

Latest News

bioAffinity Technologies Stock Surges 120% as CyPath Lung Sales Accelerate

Investor Confidence Builds Around CoreWeave and Nebius Amid AI Infrastructure Boom

Rivian Unveils R2 Pricing and Trim Levels as It Targets the Mass EV Market

Tilman Fertitta in Exclusive Talks to Acquire Caesars Entertainment

Acurx Pharmaceuticals Shares Rise on New Clinical Trial Plans

Based on Your Interest

investing
IT Services

Oracle Shares Surge After Strong Earnings and Ambitious AI Growth Outlook

March 11, 2026
amazon-2
Ecommerece

Amazon Launches Massive Bond Offering to Fuel AI Expansion

March 10, 2026
trading-chart
Electric

ATPC Expands Global Energy Ambitions Through Strategic Partnership with Citadel Investment

March 10, 2026

Recommended

Crypto

Ethereum’s Bull Case: Why Analysts See a Path to $5,000

March 9, 2026
Biotechnology

Hims & Hers Stock Soars After Strategic Partnership With Novo Nordisk

March 9, 2026
Economy

Gold Retreats as Stronger Dollar and Rising Oil Pressure Markets

March 9, 2026
Internet

Tech Giants Maintain AI Partnerships With Anthropic Despite Pentagon Blacklist

March 6, 2026
Semiconductors

Peraso’s 60 GHz Technology Powers Next-Generation Military Drone Identification System

March 6, 2026
Stoxpo

Follow us on social media:

Highlights

  • bioAffinity Technologies Stock Surges 120% as CyPath Lung Sales Accelerate
  • Investor Confidence Builds Around CoreWeave and Nebius Amid AI Infrastructure Boom
  • Rivian Unveils R2 Pricing and Trim Levels as It Targets the Mass EV Market
  • Tilman Fertitta in Exclusive Talks to Acquire Caesars Entertainment
  • Acurx Pharmaceuticals Shares Rise on New Clinical Trial Plans

Category

  • Blog
  • Communication Services
    • Entertainment
    • Internet
    • Telecommunications
  • Companies
    • Large-Cap
    • Mega-Cap
    • Micro-Cap
    • Mid-Cap
    • Small-Cap
  • Consumer Cyclical
    • Auto Manufacturers
    • Casinos & Gambling
    • Ground Transportation
    • Hospitality
      • Casinp
      • Resorts & Lodging
      • Restaurants
      • Travel
        • Airlines
    • Retail
    • Textiles, Apparel & Luxury Goods
  • Consumer Defensive
    • Beverages
    • Discount Stores
    • Distributor
    • Ecommerece
    • Electrical Equipment
    • Foods
    • Household & Personal Products
    • Leisure Products
    • Tobacco
  • Contributions
  • Crypto
    • Altcoins
    • Bitcoin
    • Ethereum
  • Economy
  • Energy
    • Electric
    • Oil & Gas
    • Renewables
  • Financial Services
    • Asset Management
    • Banks
    • Brokerages
    • Credit Services
    • Insurance
  • Healthcare
    • Biotechnology
    • Medical Devices
    • Pharmaceuticals
  • Industrials
    • Aerospace & Defense
    • Construction
    • Industrial Machinery
  • Materials
    • Building Materials
    • Chemicals
    • Gold
    • Mining
    • Silver
    • Steel
  • Q&A's
  • Real Estate
  • Technology
    • Artificial Intelligence
    • Computer Hardware
    • Consumer Electronics
    • Cybersecurity
    • IT Services
    • Semiconductors
    • Software
  • Utilities

Latest News

bioAffinity Technologies Stock Surges 120% as CyPath Lung Sales Accelerate

March 13, 2026

Investor Confidence Builds Around CoreWeave and Nebius Amid AI Infrastructure Boom

March 12, 2026
Rivian Electric Pickup Truck

Rivian Unveils R2 Pricing and Trim Levels as It Targets the Mass EV Market

March 12, 2026
  • About
  • Privacy Policy
  • Contact

© 2024 All Rights Reserved: STOXPO.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Read More

In case of sale of your personal information, you may opt out by using the link Do Not Sell My Personal Information

Accept Cookie Settings
Cookies are small text files that can be used by websites to make a user's experience more efficient. The law states that we can store cookies on your device if they are strictly necessary for the operation of this site. For all other types of cookies we need your permission. This site uses different types of cookies. Some cookies are placed by third party services that appear on our pages.
  • Always Active
    Necessary
    Necessary cookies help make a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
  • Marketing
    Marketing cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.
  • Analytics
    Analytics cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously.
  • Preferences
    Preference cookies enable a website to remember information that changes the way the website behaves or looks, like your preferred language or the region that you are in.
  • Unclassified
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
Cookie Settings

Do you really wish to opt-out?

No Result
View All Result
  • Latest News
  • Healthcare
    • Biotechnology
    • Pharmaceuticals
  • Technology
    • Software
    • Semiconductors
  • Crypto
    • Bitcoin
    • Ethereum
    • Altcoins
  • Companies
    • Micro-Cap
    • Small-Cap
    • Mid-Cap
    • Large-Cap
    • Mega-Cap
  • Q&A’s
  • Contributions

© 2024 All Rights Reserved: STOXPO.